Fulcrum Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Fulcrum Therapeutics, Inc.
CIK #0001680581
EDGAR Form CIK 2011 - 2025
10-K [0001680581]
10-Q [0001680581]
3 [0001680581]
4 [0001680581]
5 [0001680581]
8-K [0001680581]
D [0001680581]
SC 13G [0001680581]
Form 13D/13G Filer Form 13D/13G Subject Filed
Adage Capital Management LP Fulcrum Therapeutics Inc [2025-02-12]
Suvretta Capital Management LLC Fulcrum Therapeutics Inc [2025-01-06]
BlackRock Inc Fulcrum Therapeutics Inc [2024-12-06]
Nantahala Capital Management LLC Fulcrum Therapeutics Inc [2024-11-14]
BlackRock Inc Fulcrum Therapeutics Inc [2024-11-08]
BlackRock Inc Fulcrum Therapeutics Inc [2024-10-21]
TCG Crossover GP II LLC Fulcrum Therapeutics Inc [2024-09-20]
Adage Capital Partners GP LLC Fulcrum Therapeutics Inc [2023-03-06]
RA Capital Management LP Fulcrum Therapeutics Inc [2022-08-26]
Point72 Asset Management LP Fulcrum Therapeutics Inc [2022-06-22]
View All
Form 3/4/5 Subject 2011 - 2025
King Rachel K.
Fulcrum Therapeutics, Inc.
Ezekowitz Alan
Gould Robert J
Banks Sonja
Hill Colin
Haviland Kate
Dorton Katina
Geraghty James A
Tourangeau Greg
View All
Terms | Privacy | Guide
tony@aum13f.com